In pharmaceutical research, many analysts maintain that scaling up high-throughput automated synthesis in early-stage drug discovery will invariably reduce overall development timelines for breakthrough therapies. However, this reliance on automated high-throughput screening frequently leads researchers to prioritize easily synthesized, minor variations of existing compounds over structurally novel molecules. Because high-throughput platforms struggle to characterize complex biological interactions early on, promising drug candidates that require intricate synthesis pathways are routinely discarded prematurely. Consequently, laboratories that depend heavily on these automated systems ultimately spend more time troubleshooting late-stage clinical failures than those employing traditional, targeted research methodologies.
In the argument given, which of the following best describes the structural roles played by the two bolded statements?
- The first is a position that the argument aims to refute; the second is a premise offered in support of the author's overall conclusion.Cevap
- BThe first is the main conclusion of the argument; the second is an intermediate conclusion offered to support that main conclusion.
- CThe first is a judgment supported by the author; the second is a counterexample introduced to limit the scope of that judgment.
- DThe first is background information providing context for the passage; the second is the author's primary conclusion.
- EThe first is a claim accepted by the author; the second is a rebuttal introduced to qualify that claim.